MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from maturities
of marketable...
$33,666,959
Issuance of common stock
related to registered...
$9,988,270
Issuance of common stock
related to...
$1,810,813
Proceeds from exercise of
options
$12,500
Net cash provided by
investing activities
$26,273,407
Net cash provided by
financing activities
$11,811,583
Canceled cashflow
$7,393,552
Net increase
(decrease) in cash and cash...
$8,948,063
Canceled cashflow
$29,136,927
Purchases of marketable
securities
$6,590,939
Purchases of property and
equipment
$700,047
Investment in joint
ventures
$102,566
Impairment charges
$18,882,000
Stock-based compensation
expense
$2,248,053
Depreciation and
amortization
$1,106,808
Prepaid expenses and
other assets
-$585,926
Common stock issued for
financial advisory...
$135,000
Inventory
-$131,271
(gain) loss on
disposition of assets
-$82,421
Loss from equity
method investment
-$46,301
Net cash used in
operating activities
-$29,136,927
Canceled cashflow
$23,217,780
Net loss
-$46,895,936
Accounts payable,
accrued expenses and...
-$3,112,897
Change in fair value of
acquisition contingencies
$805,863
Income taxes payable
-$713,643
Realized gain on
investments
$683,365
Inventory obsolescence
expense (recovery)
-$50,944
Accounts receivable
$31,799
Deferred revenue
-$26,057
Recoveries of credit losses
$26,006
Non-cash lease expense
-$8,197
Back
Back
Cash Flow
source: myfinsight.com
Co-Diagnostics, Inc. (CODX)
Co-Diagnostics, Inc. (CODX)